Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Researchers studying receptor pharmacology should use actual peptides
Dosage and Strength : You may encounter different strengths, such as 1,000 mcg or higher, which can determine how frequently you might need the injections
Yes - the reasons for stinging are usually either swabbed area not dry, a drop of B12 at the tip of the needle (flick syringe and wait a moment) or B12 ampoule not warmed up just before injecting (especially if using fridge)
